Business Wire

YARD-FORCE-UK

Share
TV Gardener & Chartered Horticulturist, David Domoney Highlights the Best Time to Do Gardening Jobs Using Power Tools

David Domoney highlights the ever-growing garden trend of manicuring. Keeping a neat and tidy garden is important, especially with the rise in popularity of outdoor entertaining. From trimming hedges and edges of lawns to cleaning your patio for a pristine garden, choosing the right tool for the job is crucial. With so much choice in the market, selecting powered garden tools to make the job of garden manicuring both easy, professional and all importantly, fun is a hot topic. In partnering with Yard Force®, David Domoney hopes to encourage people into their gardens and highlight the right time to do specific green preening tasks in the year. Utilising the tools at the right time of the year ensures you get the most out of them as well as making sure your garden is in the best shape.

David said, “By selecting the right tool for the job, it enables you to get the task at hand done most effectively and efficiently, so you have more time to spend enjoying a beautiful garden. In learning when is best to trim hedges, mow the lawn and general garden maintenance, we make time in the garden so much more enjoyable whilst protecting garden wildlife. It opens doors to learning new gardening techniques that will become part of regular gardening routines for a well-cared-for garden.”

Yard Force® is an internationally recognised brand with years of industry experience and knowledge.

David continues, “Giving people access to a better gardening experience is always a good thing; with practical advice on making the most of their garden and the tools necessary to give great results with little effort. The more we can do using professional electric-powered equipment at the right time of year, leaves us more time to enjoy the garden.

I want to make the tasks in the garden both rewarding and fun and using practical power tools that take the hard work out of garden maintenance. The range of cordless products and battery-share technology makes the range hassle-free, convenient, and a more sustainable option for beginners and keen gardeners alike. Within Yard Force’s 40V range, there is the Cordless Lawnmower, Hedge Trimmer, Grass Trimmer which are really innovative products that showcase game-changing technology.”

The partnership between David Domoney and Yard Force continues to encourage budding gardeners and virtuosos to get outside and give their gardens the best care. Through instructive videos, demos, gardening tips and fantastic giveaways, the knowledge and expertise will promote the range and how to get the most from the tools.

Notes to Editors:

David Domoney:

David Domoney is a seasoned gardening television broadcaster and currently presents on ITV’s ‘Love Your Garden’, ‘Love Your Weekend’ and is also the gardening presenter for ITV’s ‘This Morning’. He is a winner of 30 RHS Medals with two Best in Show category trophies and the Prince Edward Award for Horticulture Excellence. David is also known for pioneering campaigns Cultivation Street as well as Illumination Street, brightening up Britain’s streets at Christmas. David also writes a gardening column for Grow Your Own magazine.

www.daviddomoney.com

Yard Force UK:

Yard Force are excited and proud to announce that we have partnered with seasoned gardening television presenter David Domoney to endorse our range of innovative, durable and high-performance garden power tools.

David is best known for presenting ITV’s most popular Gardening Show ‘Love your Garden’ and is also the resident gardening presenter for ITV’s flagship daytime show ‘This Morning’.

David's 40 years’ of experience in horticulture and dynamic enthusiastic character made him the perfect choice to collaborate with to help endorse our innovative and quality lead products.

Introducing a household name to represent our brand instils the confidence we have in our products and their performance. David says:

Like anything in the garden, once you know how, it becomes so easy. In learning how to look after our gardens properly, using power tools where needed, we make time in the garden so much more enjoyable and open doors to learning new gardening techniques and having access to a healthy and well-cared-for garden.”

We will be working closely with David throughout the year to produce top gardening tips for you to use around the garden, create some instructive videos designed to encourage you and your family to get back outside and exciting GIVEAWAYS featuring chosen products. To be in with the chance of winning and accessing these great promotions we have created a dedicated promotional code which will enable you to receive discounts and added extras all year round! All you need to do is:

SIGN UP TO RECEIVE THE PROMOTIONAL CODE below:
www.yardforce.eu/david

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230118005607/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release

Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem

Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release

Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played

Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release

At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will

Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release

Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.

MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release

MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye